Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children

被引:77
作者
Anderson, BJ
Holford, NHG
Woollard, GA
Chan, PLS
机构
[1] Auckland Childrens Hosp, Paediat Intens Care Unit, Paediat Intens Care Dept, Auckland, New Zealand
[2] Univ Auckland, Sch Med, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[3] Auckland Hosp, Dept Clin Chem, Auckland, New Zealand
关键词
acetaminophen : pharmacokinetics; CSF; effect compartment; paracetamol; pharmacodynamics;
D O I
10.1046/j.1365-2125.1998.00780.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Paracetamol has a central action for both antipyresis and analgesia. Maximum temperature decrease and peak analgesia are reported at 1-2 h after peak plasma paracetamol concentration. We wished to determine the relationship between plasma and cerebrospinal fluid (CSF) pharmacokinetics in children. Methods; Concentration-time profiles in plasma and CSF after nasogastric paracetamol 40 mg kg(-1) were measured in nine children who had indwelling ventricular drains. Estimation of population pharmacokinetic parameters was made using both a standard two-stage population approach (MKMODEL) and a nonlinear mixed effect model (NONMEM). Results were standardized to a 70 kg person using an allometric power model. Results Both approaches gave similar estimates. NONMEM parameter estimates were clearance 10.21 h(-1) (CV 47%), volume of distribution 67.11 (CV 58%) and absorption rate constant 0.77 h(-1) (CV 49%). Cerebrospinal fluid concentrations lagged behind those of plasma. The equilibration half time was 0.72 h (CV 117%). The CSF/plasma partition coefficient was 1.18 (CV 8%). Conclusions Higher concentrations in the CSF probably reflect the lower free water volume of plasma. The CSF equilibration half time suggests that CSF kinetics approximate more closely to the effect compartment than plasma, but further time is required for paracetamol to exert its effects. Effect site concentrations equilibrate slowly with plasma. Paracetamol should be given 1-2 h before anticipated pain or fever in children.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 47 条
[1]  
ANDERSON BJ, 1995, PAEDIATR ANAESTH, V5, P237
[2]   Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients [J].
Anderson, BJ ;
McKee, AD ;
Holford, NHG .
CLINICAL PHARMACOKINETICS, 1997, 33 (05) :313-327
[3]   DOUBLE-BLIND, PLACEBO CONTROLLED COMPARISON OF PARACETAMOL AND PARACETAMOL PLUS CODEINE - A QUANTITATIVE-EVALUATION BY LASER-INDUCED PAIN [J].
ARENDTNIELSEN, L ;
NIELSEN, JC ;
BJERRING, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) :241-247
[4]   PHARMACOKINETICS OF PARACETAMOL IN THE NEONATE AND INFANT AFTER ADMINISTRATION OF PROPACETAMOL CHLORHYDRATE [J].
AUTRET, E ;
DUTERTRE, JP ;
BRETEAU, M ;
JONVILLE, AP ;
FURET, Y ;
LAUGIER, J .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1993, 20 (3-4) :129-134
[5]  
BANNWARTH B, 1992, BR J CLIN PHARM, V34, P879
[6]  
BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195
[7]   ACETAMINOPHEN BLOCKS SPINAL HYPERALGESIA INDUCED BY NMDA AND SUBSTANCE-P [J].
BJORKMAN, R ;
HALLMAN, KM ;
HEDNER, J ;
HEDNER, T ;
HENNING, M .
PAIN, 1994, 57 (03) :259-264
[8]   SINGLE-DOSE PHARMACOKINETICS OF IBUPROFEN AND ACETAMINOPHEN IN FEBRILE CHILDREN [J].
BROWN, RD ;
WILSON, JT ;
KEARNS, GL ;
EICHLER, VF ;
JOHNSON, VA ;
BERTRAND, KM .
JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (03) :231-241
[9]  
Conner, 1983, ECOLOGICAL IMPLICATI, P48, DOI 10.1017/CBO9780511608551
[10]   RELATION BETWEEN MORPHINE PHARMACOKINETICS AND ANALGESIA [J].
DAHLSTROM, BE ;
PAALZOW, LK ;
SEGRE, G ;
AGREN, AJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (01) :41-53